These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8630839)

  • 1. Adverse events temporally associated with meningococcal vaccines.
    Yergeau A; Alain L; Pless R; Robert Y
    CMAJ; 1996 Feb; 154(4):503-7. PubMed ID: 8630839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso.
    Bentsi-Enchill AD; Zongo I; Khamassi S; Pless R; Thombiano R; Tiéndrebéogo S; Nelson CB; Duclos P
    Vaccine; 2007 Sep; 25 Suppl 1():A72-8. PubMed ID: 17544552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System.
    Ball R; Braun MM; Mootrey GT;
    Clin Infect Dis; 2001 May; 32(9):1273-80. PubMed ID: 11303261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal vaccine--do some children experience side effects?
    Hood DA; Edwards IR
    N Z Med J; 1989 Feb; 102(862):65-7. PubMed ID: 2919016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
    Wise RP; Iskander J; Pratt RD; Campbell S; Ball R; Pless RP; Braun MM
    JAMA; 2004 Oct; 292(14):1702-10. PubMed ID: 15479935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN; Bryant NJ; Andrews NJ; Bowley JS; Ohrling A; Verity CM; Ross EM; Miller E
    Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months.
    Prescrire Int; 2003 Apr; 12(64):43-6. PubMed ID: 12675020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.
    De Wals P; Dionne M; Douville-Fradet M; Boulianne N; Drapeau J; De Serres G
    Bull World Health Organ; 1996; 74(4):407-11. PubMed ID: 8823963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec.
    De Wals P; Deceuninck G; De Serres G; Boivin JF; Duval B; Remis R; Massé R
    Clin Infect Dis; 2005 Apr; 40(8):1116-22. PubMed ID: 15791510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events temporally associated with immunizing agents.
    Duclos P; Pless R; Koch J; Hardy M
    Can Fam Physician; 1993 Sep; 39():1907-13. PubMed ID: 8219839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
    Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N
    Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.